Robeco Institutional Asset Management B.V. decreased its stake in Xylem Inc. (NYSE:XYL - Free Report) by 15.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 184,366 shares of the industrial products company's stock after selling 33,684 shares during the period. Robeco Institutional Asset Management B.V. owned 0.08% of Xylem worth $23,850,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also modified their holdings of the company. Valley National Advisers Inc. grew its stake in Xylem by 84.9% in the first quarter. Valley National Advisers Inc. now owns 220 shares of the industrial products company's stock valued at $26,000 after purchasing an additional 101 shares in the last quarter. Perkins Coie Trust Co bought a new stake in shares of Xylem during the 1st quarter worth approximately $27,000. Maseco LLP acquired a new stake in shares of Xylem in the 2nd quarter valued at approximately $31,000. ST Germain D J Co. Inc. grew its stake in shares of Xylem by 950.0% in the second quarter. ST Germain D J Co. Inc. now owns 252 shares of the industrial products company's stock valued at $33,000 after buying an additional 228 shares in the last quarter. Finally, Center for Financial Planning Inc. increased its holdings in Xylem by 52.0% during the first quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock worth $32,000 after buying an additional 91 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company's stock.
Xylem Stock Performance
NYSE:XYL opened at $149.99 on Friday. The stock has a market cap of $36.51 billion, a P/E ratio of 38.96, a PEG ratio of 2.59 and a beta of 1.13. The stock has a 50 day simple moving average of $141.96 and a 200 day simple moving average of $129.48. The company has a current ratio of 1.90, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. Xylem Inc. has a 1-year low of $100.47 and a 1-year high of $150.98.
Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, beating analysts' consensus estimates of $1.15 by $0.11. The firm had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.20 billion. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The company's revenue for the quarter was up 6.1% on a year-over-year basis. During the same period in the prior year, the firm posted $1.09 EPS. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Research analysts anticipate that Xylem Inc. will post 4.65 earnings per share for the current year.
Xylem Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Thursday, August 28th were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend was Thursday, August 28th. Xylem's dividend payout ratio (DPR) is currently 41.56%.
Insiders Place Their Bets
In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the business's stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $139.96, for a total value of $139,960.00. Following the completion of the sale, the chief accounting officer owned 2,957 shares of the company's stock, valued at $413,861.72. The trade was a 25.27% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.27% of the stock is owned by company insiders.
Analysts Set New Price Targets
A number of analysts have commented on XYL shares. Wall Street Zen upgraded shares of Xylem from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. Mizuho raised their target price on shares of Xylem from $125.00 to $140.00 and gave the company a "neutral" rating in a research note on Friday, September 12th. Stifel Nicolaus lifted their price target on Xylem from $162.00 to $175.00 and gave the stock a "buy" rating in a report on Friday, August 1st. Citigroup restated a "buy" rating and issued a $152.00 price objective (up previously from $137.00) on shares of Xylem in a research note on Monday, July 14th. Finally, Cowen reaffirmed a "hold" rating on shares of Xylem in a research report on Tuesday, August 26th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $152.33.
Read Our Latest Stock Analysis on Xylem
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.